Position in LQDA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$27,382,790
+$26,989,082 QoQ
Shares Held
343,444
+946.8% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 334 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $549,104,897 across 28 Drug Manufacturers - Specialty & Generic names. LQDA ranks #9 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,360 | $59,091,431 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
1,667,073 | $57,797,420 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
106,561 | $57,737,945 | |
| 4 | ALKS |
Alkermes plc.
|
983,822 | $51,552,272 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
239,193 | $40,313,587 | |
| 6 | ZTS |
Zoetis Inc.
|
527,859 | $37,931,946 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
772,174 | $31,682,298 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,133,913 | $27,905,598 |
All Filings in LQDA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,382,790 | 343,444 | Shares | Defined | 2026-08-04 | |
| 2024-06-30 | $393,708 | 32,809 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $537,813 | 36,462 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $206,602 | 17,174 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $111,583 | 17,600 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $137,068 | 17,461 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $169,737 | 24,564 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $171,269 | 26,887 | Shares | Defined | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||